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In addition, all HBP pharmacologic treatments are associated with the potential for adverse effects, and all incur an inconvenience and cost that an individual patient would have to balance against the possibility of benefit.
In their recent article in the January/February 2018 issue of CPJ, 2 the authors presented what they felt were the update highlights and the important elements from the most recent 2017 Hypertension Canada guidelines. 3 I read their article with the eye of seeing if one could extract information from this update that would help pharmacists engage in SDM. It was disappointing to find that within the 9 pages of this article, there was not a single mention of the following key aspects/treatment information:
1. Patient values and preferences-There was no mention of patient values and preferences, and in fact, a number of phrases used by the authors, such as "Antihypertensive therapy should be provided to all patients, " "Antihypertensive therapy should be strongly considered, " "All patients should be treated to achieve a SBP target" and "strongly recommend antihypertensive therapy for most patients, " seem to fly in the face of a SDM concept. In my opinion, the above (both evidence and approaches to treatment) would be useful and, I would say essential, to have when it comes to SDM. I realize this article was not intended to be an exhaustive discussion of HBP treatment, but surely if the authors felt any of the above issues were important to pharmacists, they would have at least been mentioned somewhere within the 9 pages, almost 4000 words, 1 box and 1 figure of their article. Unfortunately, in hindsight, it isn't completely surprising that these aspects were missing because the actual 2017 Hypertension Canada guidelines are also mute on many of these aspects. 3 Both the guidelines and this update seem to be very much focused on improving adherence and blood pressure control. While these 2 concepts are not unimportant, they are very medication and threshold centric. Pharmacists are ideally suited to help people make decisions about HBP treatment, but if the "experts" don't promote SDM or provide the necessary information to do SDM, 
Lifestyle recommendations (nutrition and physical activity)-No

